Table 3 Metabolic syndrome components in the case and control groups.
Clinical examinations | Case | Control | P- value | ||||
|---|---|---|---|---|---|---|---|
Max | Min | SD ± Mean | Max | Min | SD ± Mean | ||
Height (cm) | 186 | 150 | 8.31 ± 161.82 | 188 | 80 | 20.22 ± 159.02 | 0.276 |
Weight (kg) | 100 | 46 | 12.59 ± 73.04 | 100 | 16 | 19.37 ± 66.58 | 0.110 |
BMI kg/m2)) | 36.80 | 18.35 | 4.62 ± 28.10 | 37.65 | 12.62 | 4.80 ± 25.69 | 0.012 |
WC* (cm) | 122 | 75 | 11.92 ± 97.14 | 117 | 21 | 18.88 ± 86.74 | 0.004 |
HDL * (mg/dL) | 75 | 29 | 9.94 ± 49.52 | 78 | 34 | 9.58 ± 50.70 | 0.746 |
FBS (mg/dL)* | 192 | 77 | 22.51 ± 100.16 | 295 | 76 | 39.56 ± 108.62 | 0.089 |
TG (mg/dL)* | 435 | 51 | 84.06 ± 176.22 | 258 | 31 | 62.69 ± 125.32 | 0.001 |
SBP (mm Hg)* | 170 | 100 | 13.85 ± 118.60 | 190 | 80 | 18.67 ± 120.60 | 0.677 |
DBP (mm Hg,)* | 100 | 60 | 7.27 ± 80.40 | 130 | 60 | 11.37 ± 78.20 | 0.080 |